Clinical trial for Covid19 Virus Infection
Official title Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
ClinicalTrials.gov ID: NCT04790240
What this study is testing
- What it's testing
- The study aims to see if a combination of medical herbs can reduce the immune over‑reaction (cytokine storm) and allow T cells to clear the virus.
- Who it's for
- Adults who have tested positive for COVID‑19 infection.
- What's involved
- Participants will take the herbal preparation and have regular check‑ups, including blood tests and symptom assessments, to monitor immune response.
- Time commitment
- The trial lasts several weeks with visits at the clinic for dosing and follow‑up assessments.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Individuals diagnosed with COVID-19 virus infection in the past 1-20 days must submit the proved metrics of COVID-19 virus marks positive during the...
- The age of participants is between 10-70 years old;
- The participants are received or not received conventional medication treatment, and continuing the treatment patients, could be enrolled in this...
- This clinical study is not restricted to gender, age, sex, race, and nationality;
- The participants must have reports of CBC, C3, C4, IgM, IgG, CD4/CD8, and lungs' images ready before the clinical study;
You likely can't join if
- Individuals with a prior COVID-19 virus infection that no longer shows up from COVID-19 testing;
- Children who are younger than 10-year-old, cannot control themselves to take the medical herbs on time;
- Elders whose age beyond 70-year-old, with severe underline illness;
- COVID-19 virus-infected patients who do not feel willing to take medical herbs;
- Patients diagnosed with COVID-19 virus infection cannot consistently finish the treatment courses for a specific reason;
- Patients diagnosed with COVID-19 virus infection but do not willing to share their information with the public;
See the full eligibility criteria
- Individuals diagnosed with COVID-19 virus infection in the past 1-20 days must submit the proved metrics of COVID-19 virus marks positive during the registration;
- The age of participants is between 10-70 years old;
- The participants are received or not received conventional medication treatment, and continuing the treatment patients, could be enrolled in this clinical study;
- This clinical study is not restricted to gender, age, sex, race, and nationality;
- The participants must have reports of CBC, C3, C4, IgM, IgG, CD4/CD8, and lungs' images ready before the clinical study;
- The Participants must repeat the evaluation experiment during and at the end of the clinical study.
- Individuals with a prior COVID-19 virus infection that no longer shows up from COVID-19 testing;
- Children who are younger than 10-year-old, cannot control themselves to take the medical herbs on time;
- Elders whose age beyond 70-year-old, with severe underline illness;
- COVID-19 virus-infected patients who do not feel willing to take medical herbs;
- Patients diagnosed with COVID-19 virus infection cannot consistently finish the treatment courses for a specific reason;
- Patients diagnosed with COVID-19 virus infection but do not willing to share their information with the public;
- Current or past participation within a specified timeframe in another clinical trial, as warranted by this intervention's administration;
- Severe patients, when there have insufficient normal cells, can be adjusted, with pre-list diseases life-threatening.
The study team makes the final eligibility decision.
Where it is enrolling
- Rockville, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rockville, Maryland, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.